ENDPOINTS

Q&A: Sandoz CEO talks generic GLP-1s, Trump's tariffs, Mark Cuban's company

Richard Saynor’s journey to becoming a self-described patent destroyer was largely by accident. Saynor has been CEO of Sandoz since 2019, but he started his career as a pharmacist before finding the job frustrating and ...

Jun 3, 2025 - 12:04
 0
Q&A: Sandoz CEO talks generic GLP-1s, Trump's tariffs, Mark Cuban's company
Richard Saynor’s journey to becoming a self-described patent destroyer was largely by accident. Saynor has been CEO of Sandoz since 2019, but he started his career as a pharmacist before finding the job frustrating and ...
Read More

Tags:

Previous Article

Get Ready: Strapping Machine Market is Gearing Up for Growth

Next Article

Disaster relief needs community trust — authorities must earn it

Related Posts

SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M

SK, Carlyle bolster bluebird bio bid; Therini Bio raise...

May 14, 2025  0

Will the FDA approve Moderna's next-gen Covid shot?

Will the FDA approve Moderna's next-gen Covid shot?

May 28, 2025  0

Regeneron makes $80M obesity deal with Hansoh

Regeneron makes $80M obesity deal with Hansoh

Jun 2, 2025  0